Tyler Golato
Co-Initiator 於 VitaDAO · Partner 於 Triplicate · Co-Founder 於 Molecule · Co-Initiator 於 BIO Protocol
Tyler Golato 是 Triplicate 的合夥人，也是 Molecule（一個藥物開發的開源協議）的共同創辦人。此前，他在美國國家老化研究所（NIH/NIA/IRP）工作，在 Dr. David M. Wilson III 和 Dr. Vilhelm Bohr 的指導下，專注於修復內源性 DNA 損傷，特別是在老化的背景下。此外，Tyler 共同創辦了 VitaDAO 和 bio.xyz。在投入 DeSci 之前，Tyler 早期在生物化學、分子生物學和老年生物學領域有傑出的職業生涯。
目前職位
投資
新聞提及
May in the Biosphere 🌐 - PeptAI Ignition Sale: 32x+ oversubscribed, 1.6M+ USDC committed by 1.4K+ participants. veBIO staker reward claims now live in the Bio app. Next: first on-chain wet-lab attestation via Molecule Labs in Q2. - BIO on Robinhood: $BIO is now tradable on @RobinhoodApp, bringing
The chemical universe is too massive for brute-force computing. "It would take over 170 years to brute force this data set by running inference on every single possible molecule." @metanova_labs #SN68 "Nova blueprint" incentivizes global miners to design and open-source their algorithmic shortcut
hot take: a single water molecule isn't wet. but two are.
This AI Reads Your Chemistry Instructions and Finds the Best Way to Build You a Molecule
For a decade, AI, Web3, and Bio have scaled as parallel frontiers, but that era is ending.The defining companies of the
For a decade, AI, Blockchain, and Bio have scaled as parallel frontiers - but that era is ending.The defining companies
We're excited to announce The Convergence, YZi Labs' flagship conference of the year. On May 12 at the iconic Computer H
The scientist who would have studied your disease probably chose a different problem.
Most people describe biotech companies as a jump from discovery to application.
Prompt-to-DeFi Strategist Challenge: BNB Chain Edition